Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
May 20, 2019

AbbVie stops phase 3 glioblastoma trial of Depatux-M over futility

AbbVie has discontinued an ongoing phase 3 trial evaluating its antibody drug conjugate (ADC) depatuxizumab mafodotin (Depatux-M) for the treatment of newly diagnosed glioblastoma (GBM), an aggressive type of brain cancer, owing to futility.

Continue
Image: Futility forces AbbVie to drop INTELLANCE-1 study of Depatux-M. Photo: courtesy of AbbVie Inc.
May 17, 2019

Pfizer’s blood clot drug Fragmin gets FDA approval for pediatric patients

Image: FDA expands approval of Pfizer’s blood clot drug Fragmin to cover pediatric patients. Photo: courtesy of Coolcaesar/Wikipedia.org.
May 16, 2019

FDA approves Roche’s leukemia drug combo Venclexta plus Gazyva

Image: Site Roche Basel. Photo: courtesy of F. Hoffmann-La Roche Ltd.

Contracts

March 11, 2019

TaiwanJ Pharmaceuticals out-licenses liver drug candidate in Asia

Image: TaiwanJ Pharmaceuticals obtained $26m deal for licensing and co-development contract with Newsoara Biopharma on JKB-122 Asian rights. Photo: courtesy of rawpixel/Unsplash.com.

GeoVax, Leidos expand collaboration to malaria vaccines

World’s largest pharmaceutical firm selects ValGenesis to standardize corporate validation process enterprise-level

Amprologix wins DHSC backing for new antibiotic

Deals

Deals May 20, 2019

Ligand licenses VER250840 to Cumulus Oncology

Pharmaceutical Business Review

Thermo Fisher Scientific to acquire manufacturing site in Cork, Ireland, from GSK

ESSA Pharma to acquire Realm Therapeutics

Novartis to buy Takeda’s dry eye drug Xiidra for $3.4bn

Popular

  1. US FDA approves GATTEX for children with short bowel syndrome
  2. Pfizer’s Abrocitinib yields positive results in phase 3 moderate to severe AD trial
  3. Allegro announces positive results of ex-US proof-of-concept trial with ALG-1007 for dry eye disease
  4. Exelixis’ collaborator Daiichi Sankyo launches MINNEBRO (Esaxerenone) tablets in Japan
  5. Novartis’ Gilenya proves superiority over glatiramer acetate in relapsing remitting MS

PRESS RELEASES

Upcoming Pharma Training from NSF
Upcoming Pharma Training from NSF
Pfanstiehl Launches cGMP-Produced, Parenteral-Grade Mannitol
Pfanstiehl Launches cGMP-Produced, Parenteral-Grade Mannitol
Join Royal Pharmaceutical Society’s 16th Joint Qualified Person Symposium
Join Royal Pharmaceutical Society’s 16th Joint Qualified Person Symposium
Injecting Beauty Made Easy
Injecting Beauty Made Easy
Rethinking Pharma Packaging
Rethinking Pharma Packaging

Suppliers

Whitepapers

Validated Metal Analysis of Injectable Grade Platform Excipients
Validated Metal Analysis of Injectable Grade Platform Excipients
Narrowing the Gap Between Active Ingredients and Critical Excipients
Narrowing the Gap Between Active Ingredients and Critical Excipients
Trehalose: A Powerful Excipient in the Formulation Toolbox
Trehalose: A Powerful Excipient in the Formulation Toolbox